The effect of ketamine on the incidence of emergence agitation in children undergoing tonsillectomy and adenoidectomy under sevoflurane general anesthesia by Lee, Yoon Sook et al.
Korean J Anesthesiol 2010 May; 58(5): 440-445 
DOI: 10.4097/kjae.2010.58.5.440  Clinical Research Article
Copyright ⓒ Korean Society of Anesthesiologists, 2010 www.ekja.org
Background:  The rapid emergence and recovery from general anesthesia afforded by sevoflurane is associated with 
a high incidence of emergence agitation in children.  Small doses of ketamine reduce the incidence of emergence 
agitation.  This study compared the effects of ketamine 0.25 mg/kg and 0.5 mg/kg on emergence agitation and 
postoperative pain.
Methods:  The effects of added intravenous ketamine were evaluated in 93 children, ASA I-II, 2-14 years old, 
undergoing an adenotonsillectomy.  The patients were allocated randomly to one of three groups receiving saline 
(group C), ketamine 0.25 mg/kg (group K0.25) or ketamine 0.5 mg/kg (group K0.5).  The children in each group were 
administered the study drugs 10 minutes before the end of surgery.  The recovery characteristics, including the time 
to extubation, delivery time from the PACU, postoperative nausea and vomiting, agitation and pain were assessed.
Results:  There were no significant differences in the extubation time, delivery time and postoperative nausea and 
vomiting between the three groups.  There were significant differences in modified CHEOPS (Children's Hospital of 
Eastern Ontario Pain Scale) between the three groups.  The incidence of emergence agitation was low in the K0.25 
and K0.5 groups compared to the control group. However, there was no significant difference between the K0.25 and 
K0.5 groups.
Conclusions:  There was no significant difference in the incidence of emergence agitation between K0.25 and K0.5 
groups.  However, K0.5 group showed a lower pain score than K0.25 group.  (Korean J Anesthesiol 2010; 58: 440-445)
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Introduction
    Sevoflurane is an inhalation anesthetic agent used frequently 
to induce and maintain outpatient or pediatric anesthesia due 
to its excellence in hemodynamic stability, less irritation of the 
mucous membranes and low blood solubility, which causes 
rapid induction and emergence from anesthesia and controls 
the anesthesia depth [1,2]. However, it has been reported that 
there are risks with emergence agitation, the incidence rate of 
which is particularly high in children, ranging from 30 to 80% 
of those undergoing general anesthesia with sevoflurane. There 
have been many studies on the causes of emergence agitation 
and/or the preventive effects against emergence agitation, but 
the pathogenesis and preventive treatments are not completely 
understood. 
    Ketamine is an effective drug for sedation, analgesia and 
amnesia. Kararmaz et al. [3] administered 6 mg/kg ketamine 
orally as preoperative medication to patients and reported a 
decrease in the incidence of emergence agitation without a 
delay in recovery. The effect of ketamine on decreasing the 
incidence of emergence agitation was confirmed by Abu-
Shahwan et al. [4], who injected 0.25 mg/kg ketamine intra-
venously 10 minutes before the completion of surgery.
    Following these studies, in this study, two different doses 
of ketamine, 0.25 mg/kg and 0.5 mg/kg, was administered 10 
minutes before the end of surgery, and the development of 
emergence agitation, postoperative pain intensity, effects on 
recovery and incidence of side-effects were compared. 
Materials and Methods
    The institutional review board approved this study and the 
patient’s guardians provided informed consent after giving a 
full explanation of the purpose and procedure of this study. 
Ninety three children, aged between 2-14 years, with American 
Society of Anesthesiologists (ASA) physical status I-II, who 
were scheduled to undergo an adenotonsillectomy (or adeno-
idectomy) under general anesthesia, were enrolled this study. 
Children with cognitive or developmental disorders were 
excluded.
    The patients were allocated randomly to one of three groups: 
the control group (administered with a saline solution 10 min 
before the end of surgery, n = 31), K0.25 group (administered 
with 0.25 mg/kg of ketamine 10 min before the end of ope-
ration, n = 31), and K0.5 group (administered with 0.5 mg/kg 
of ketamine 10 min before the end of surgery, n = 31). There 
were no significant differences in age, gender, height, weight, 
American Society of Anesthesiologists physical status and the 
length of anesthesia and operation between the three groups 
(Table 1).
    Atropine 0.01 mg/kg as a premedication was injected intra-
muscularly 30 min before the induction of anesthesia. Upon the 
patients’ arrival into the operating room, the blood pressure, 
electrocardiogram and pulse oximetry were monitored. 
Thiopental sodium 5 mg/kg and rocuronium 0.6 mg/kg were 
administered intravenously, and endotracheal intubation was 
performed. Anesthesia was maintained with oxygen 1.5 L/
min, nitrous oxide 1.5 L/min and sevoflurane at 1.5-3.0 vol%, 
while controlled ventilation was performed to sustain the end-
tidal carbon dioxide (ETCO2) between 30 and 35 mmHg. Ten 
minutes before the end of surgery, the experimental drugs were 
administered by physicians not participating in the anesthesia, 
5 ml in total. The removal time of the mouth gag defined the 
termination of surgery. At the end of surgery, the administration 
of sevoflurane and nitrous oxide was discontinued, and manual 
ventilation was then performed with 100% oxygen at 6 L/min. 
Pyridostigmine 0.2 mg/kg and glycopyrrolate 0.008 mg/kg 
were administered to reverse the residual muscle relaxation. 
Extubation was performed when the patients’ gag reflex was 
restored and they showed facial grimaces or purposeful-
appearing motor movements, and the time period from the end 
of surgery to the extubation time was recorded. The time span 
from the attachment of the basic monitoring system until the 
extubation time was recorded as the duration of anesthesia, 
whereas the time span between the insertion and removal of 
the cheek distender was recorded as the duration of surgery. 
Upon extubation, the patients were transferred to the post-
anesthesia care unit (PACU), where their emergence agitation 
Table 1. Demographic Data
Group C (n = 30) K0.25 (n = 30) K0.5 (n = 30)
Age (years)
Sex (M : F)
Height (cm)
Weight (kg)
ASA (I : II)
Duration of anesthesia (min)
Duration of operation (min)
7.00 (5.06, 9.15)
  20 : 10
  123.20 (109.88, 135.35)
26.15 (18.34, 39.05)
30 : 0
55.00 (50.00, 65.00)
34.00 (22.00, 40.00)
6.08 (5.08, 7.10)
 17 : 13
  115.00 (109.75, 120.25)
22.00 (19.04, 25.85)
30 : 0
60.00 (48.75, 70.00)
32.50 (24.75, 45.50)
6.58 (5.67, 8.58)
  18 : 12
  118.00 (113.58, 127.75)
21.75 (19.50, 30.99)
28 : 2
60.00 (50.00, 75.00)
35.00 (25.00, 50.75)
Values are median (25%, 75%). There are no significant differences among the three groups.442 www.ekja.org
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was observed by nurses who were blinded to the patients’ 
groups. Emergence agitation was assessed using a simple four-
point scale as follows: 1, asleep; 2, awake but calm; 3, agitated 
but consolable; and 4, severely agitated and difficult to console. 
Upon admission to the PACU and at every five minutes, the 
patients’ emergence behavior was measured and the highest 
score was recorded during the PACU stay.
    The level of nausea was evaluated using a four-point scale to 
check for the incidence of adverse events as follows: 1, none; 
2, nausea only; 3, one episode of vomiting; and 4, more than 2 
episodes of vomiting. Recurrent vomiting within 5 minutes was 
considered to be one single episode. Ondansetron 0.15 mg/
kg was provided as an antiemetic drug. If the vomiting was not 
controlled, repeated administration was performed until the 
total dose reached 4 mg.
    Postoperative pain was assessed using the modified Children's 
Hospital of Eastern Ontario Pain Scale (CHEOPS) and measured 
upon admission to the PACU, and then pain was measured 
every five minutes until the time of discharge from the PACU. 
During the PACU stay, the highest score at any time was recorded.
    The agitated children were managed by administering 
fentanyl 1.0 μg/kg with at least a 10-minute interval between 
each dose. The drug was discontinued as soon as the symptoms 
had disappeared. 
    Modified Aldrete postanesthesia score (Table 2) was adopted 
as the discharge criteria according to which a score >9 is 
needed for discharge. Patients who fulfilled the discharge 
criteria were transferred to the ward unit and the delivery time 
was recorded.
    Statistical analysis was performed using SPSS 12.0 (SPSS Inc., 
Chicago, IL, USA). Continuous variables, such as age, height, 
weight, duration of anesthesia, duration of surgery, duration 
of extubation after the end of surgery, duration of the PACU 
stay, and modified CHEOPS were confirmed to follow a normal 
distribution. Among the variables, duration of extubation, 
which was reported as the mean ± SD, was analyzed using one-
way ANOVA, whereas the other continuous variables were 
examined using a Kruskal-Wallis test. The categorical variables 
were compared using a Chi-square test for gender and a 
Fisher's exact test for the ASA, postoperative nausea/vomiting 
scores, and Emergence Agitation scores. A P value < 0.05 was 
considered significant.
Results
    Of the 93 patients, one out of each group experienced 
laryngospasm after extubation and were excluded. No side-
effects such as hallucination or nightmare were observed in the 
groups administered with ketamine. There were no significant 
differences in both the time span from the end of surgery until 
the extubation time and the time span from the arrival at the 
PACU to the transfer to the ward unit between the three groups. 
Postoperative pain scores showed significant differences 
between the three groups, where the scores were significantly 
different not only between the control group and K0.25 group, 
Table 4. Extubation time, Delivery Time, and PONV (Postoperative Nausea, Vomiting)
Group C (n = 30) K0.25 (n = 30) K0.5 (n = 30)
Extubation time (min)
Delivery time (min)
PONV (1 : 2 : 3 : 4)
10.24 ± 3.66
40.00 (40.00, 50.00)
24 : 4 : 2 : 0
11.28 ± 3.19
40.00 (40.00, 50.00)
26 : 0 : 4 : 0
10.69 ± 3.34
40.00 (36.50, 50.00)
23 : 1 : 6 : 0
Values of extubation time are mean ± SD. Values of delivery time are median (25%, 75%). There are no significant differences among the three 
groups. PONV scale : 1 = none, 2 = retching, 3 = one episode of vomit, 4 = multiple episode of vomit.
Table 3. Modified CHEOPS (Children's Hospital of Eastern Ontario 
Pain Scale)
Score 0 1 2
Cry
Facial
Verbal
Torso
Legs
No Cry
Smiling
Positive
Neutral
Neutral
Crying, moaning
Composed
None or other complaints
Shifting, tense, upright
Kicks, squirm, drawn up
Scream
Grimace
Pain complaint
Restrained
Restrained
Table 2. The Modified Aldrete Postanesthesia Score
Criteria Point value
Oxygenation
    SpO2 > 92% on room air
    SpO2 > 90% on oxygen
    SpO2 < 90% on oxygen
Respiration
    Breathes deeply and coughs freely
    Dyspnoeic, shallow or limited breathing
    Apnoea
Circulation
    Blood pressure ±20 mmHg of normal
    Blood pressure ±20-50 mmHg of normal
    Blood pressure more than ±50 mmHg of normal
Consciousness
    Fully awake
    Aousable on calling
    Not responsive
Activity
    Moves all extremities
    Moves two extremities
    No movement
2
1
0
2
1
0
2
1
0
2
1
0
2
1
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between the control group and K0.5 group, but also between 
the K0.25 and K0.5 group (Table 3). No significant differences in 
the incidence of nausea and vomiting were observed between 
the groups (Table 4).
    As for Emergence Agitation scores, there existed significant 
differences between the control and K0.25 group, and between 
the control and K0.5 group, whereas no significant differences 
were detected between the K0.25 and K0.5 group (Table 5).
Discussion
    Sevoflurane is an inhalational anesthetic that is used widely 
as pediatric or outpatient anesthesia due to its excellence in 
hemodynamic stability and low blood solubility, which allows 
rapid induction and emergence from general anesthesia, 
and allows control of the depth of anesthesia. However, 
when sevoflurane is used alone, it is associated with a higher 
incidence of emergence agitation (EA) in children. The rapid 
removal of residual anesthetics due to the low blood solubility 
of sevoflurane has been suggested to cause EA in some 
patients [1,5-10]. In addition, a variety of other explanations 
have been proposed for the etiology of EA. These include the 
lack of a young child’s ability to adapt to sudden changes due 
to an unfamiliar environment after awakening, immature 
neurological development, anxiety from being separated 
from their parents, increased pain sensation, sympathetic 
hyperactivation, etc [5,10-12].
    EA is characterized by self-limiting aggressive agitation that 
develops in the early phase of awakening from anesthesia at 
the end of surgery. The term ‘Delirium’ is sometimes used to 
describe such a state [10] but other terms, such as ‘agitation’ 
or ‘excitation’ , are usually preferred because it is not feasible to 
evaluate a young child’s psychological state during emergence. 
EA can be dangerous to patients, particularly to young children. 
Patients suffering from EA may harm themselves and dislodge 
drains or catheters, which will affect the results of surgery. 
They may inflict a bodily injury on their parents [caregivers] or 
cause a paranoiac accident, which makes the management and 
monitoring of patients at the PACU difficult [13-15]. 
    Furthermore, it is difficult to differentiate between pain and 
EA in young patients because they are poor at expressing their 
pain and because EA mostly disappears within 15 minutes [4]. 
Therefore, it is possible to misunderstand self-limiting EA as 
pain and administer analgesics, such as fentanyl, which creates 
confusion because of its similarity to the time of pain being 
controlled. 
    There have been many attempts to reduce the incidence of EA 
by propofol [16,17], fentanyl [18], ketamine [3,4,19], ketolorac 
[20], nalbuphine [19], etc., but the etiology and preventive 
treatments of EA are still unclear.
    Ketamine is a N-methyl-D-aspartate (NMDA) receptor 
antagonist with a strong analgesic effect at a less than 
anesthesia-inducting dose [21]. It does not cause respiratory 
depression at small doses (<1 mg/kg), and has little effect 
on the heart rate and blood pressure [22]. The incidence of 
arousal responses, such as nightmares or hallucinations, which 
restrains the clinical employment of ketamine, is 5-30% at large 
doses of ketamine [23]. However, the incidence is lower at small 
doses (<1 mg/kg) compared to opioids [24]. This study did not 
encounter a case of hemodynamic instability, or postoperative 
hallucinations or nightmares. 
    Kawaraguch et al. [25] reported that the administration of 
ketamine 1 mg/kg after the induction of anesthesia and the 
instillation of ketamine 1 mg/kg/hr during surgery in pediatric 
strabismus surgery succeeded in decreasing EA. Abu-Shahwan 
et al. [4] showed that an intravenous injection of ketamine 0.25 
mg/kg, 10 min before the end of surgery in a dental operation 
for young children under general anesthesia with sevoflurane 
decreased the incidence of EA without a delay in recovery. 
Dalens et al. [19] reported that the intravenous administration 
of ketamine 0.25 mg/kg or nalbuphine 0.1 mg/kg in general 
anesthesia with sevoflurane for young children undergoing 
magnetic resonance imaging was effective in preventing the 
incidence of EA without delaying awakening or recovery. The 
present study was designed to compare the effects of small 
doses of ketamine, 0.25 mg/kg and 0.5 mg/kg, which are 
hemodynamically stable and have fewer side effects, such as 
hallucinations or nightmares, on EA and postoperative pain. In 
contrast to the control group, the K0.25 and K0.5 groups showed 
a decrease in the incidence of EA and a significant decrease in 
pain intensity at the PACU. Compared to the K0.25 group, the 
K0.5 group showed a significant decrease in pain intensity at 
the PACU but not in the incidence of EA, which suggests that an 
increase in the ketamine dose was effective in analgesic action, 
Table 5. Pain Score (Modified CHEOPS), and Agitation Score
Group C (n = 30) K0.25 (n = 30) K0.5 (n = 30)
Modified CHEOPS
Agitation score (1 : 2 : 3 : 4)
8.00 (6.00, 9.00)
1 : 5 : 14 : 10
3.00 (2.00, 6.00)*
11: 9 : 8 : 2*
2.00 (1.00, 2.00)*,†
17 : 11 : 2 : 0*
Values of modified CHEOPS are median (25%, 75%). Agitation score : 1 = asleep, 2 = awake and calm, 3 = agitated but consolable, 4 = severely 
agitated and inconsolable. *P < 0.05 compared with the Group C, 
†P < 0.05 compared with the Group K0.25.444 www.ekja.org
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whereas the increase in dose did not affect the incidence of 
EA. Therefore, it is believed that besides pain, a variety of other 
causes should make a contribution to the incidence of EA. 
Hence, a dose of ketamine 0.25 mg/kg alone administered 10 
min before the end of surgery would reduce the incidence of EA 
due to the combined analgesic and sedative action of ketamine. 
Although ketamine 0.5 mg/kg did not further decrease the 
incidence of EA compared to ketamine 0.25 mg/kg, a dose 
of 0.5 mg/kg is recommended for clinical treatment because 
of the significant analgesic effect at the PACU. Regarding the 
mechanism of ketamine in reducing the incidence of EA, 
Lerman et al. [26] suggested that ketamine inhibits the central 
nervous system effect in ether-linked inhalation anesthetics, 
which is responsible for increasing the incidence EA after 
anesthesia with sevoflurane. 
    The bronchodilating characteristics of ketamine was ex-
pected to be effective in preventing the severity of laryngo-
spasm after extubation in young children undergoing an 
adenotonsillectomy but one from each group experienced 
laryngospasm after extubation and were excluded. Compared to 
the control group, the K0.25 and K0.5 groups did not affect the 
delay in extubation or recovery time, or increase the incidence 
of nausea and vomiting. 
    This study had some limitations. First, the three groups did 
not demonstrate any significant differences in terms of age, 
even though the study was conducted on children, ranging 
in age from 2 to 14 years, and was not restricted to preschool 
children particularly vulnerable to EA. Second, the reason the 
adenotonsillectomy i.e. severe inflammation in the pharyngeal 
tonsil or problematic snoring, was not examined, even 
though postoperative pain, which is greater in case of severe 
inflammation in the pharyngeal tonsil, can be another variable 
in the pain scores and the incidence of EA. Further study giving 
more consideration to such limitations will be needed for more 
reliable research results. 
    In conclusion, a dose of 0.25 mg/kg or 0.5 mg/kg of ketamine, 
administered intravenously 10 min before the end of surgery, 
successfully reduced the incidence of EA without any particular 
side-effects or delays in recovery. Although the administration 
of ketamine 0.5 mg/kg did not decrease the incidence of EA 
more than that of ketamine 0.25 mg/kg, ketamine 0.5 mg/kg had 
significant analgesic effects on postoperative pain at the PACU. 
Therefore, 0.5 mg/kg ketamine, which decreases the incidence 
of EA and has postoperative analgesic effect, is recommended 
as the appropriate dose. 
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